Echo Street Capital Management LLC Blueprint Medicines Corp Transaction History

Echo Street Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $161,476 - $227,238	3,443 Added 57.63%	9,417 $472,000
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $252,102 - $396,494	5,974 New	5,974 $377,000
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $242,110 - $376,767	4,849 New	4,849 $320,000
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $603,482 - $742,683	-6,403 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $238,567 - $322,498	2,946 Added 85.22%	6,403 $658,000
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $311,335 - $379,861	-3,761 Reduced 52.11%	3,457 $304,000
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $654,744 - $781,565	7,218 New	7,218 $702,000
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $842,453 - $1.18 Million	-12,678 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $723,787 - $1 Million	12,678 New	12,678 $989,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.